Equitable Trust’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.9M | Buy |
52,651
+142
| +0.3% | +$33.1K | 0.59% | 38 |
|
|
2025
Q4 | $10.9M | Sell |
52,509
-2,072
| -4% | -$410K | 0.49% | 43 |
|
|
2025
Q3 | $10.1M | Buy |
54,581
+1,921
| +4% | +$329K | 0.47% | 46 |
|
|
2025
Q2 | $8.04M | Sell |
52,660
-2,415
| -4% | -$371K | 0.4% | 52 |
|
|
2025
Q1 | $9.13M | Sell |
55,075
-1,251
| -2% | -$196K | 0.51% | 42 |
|
|
2024
Q4 | $8.15M | Sell |
56,326
-417
| -0.7% | -$64.6K | 0.45% | 41 |
|
|
2024
Q3 | $9.2M | Buy |
56,743
+6,166
| +12% | +$982K | 0.59% | 36 |
|
|
2024
Q2 | $7.39M | Sell |
50,577
-4,848
| -9% | -$721K | 0.51% | 41 |
|
|
2024
Q1 | $8.77M | Sell |
55,425
-3,425
| -6% | -$545K | 0.61% | 36 |
|
|
2023
Q4 | $9.22M | Sell |
58,850
-79,175
| -57% | -$12.1M | 0.69% | 29 |
|
|
2023
Q3 | $21.5M | Sell |
138,025
-8,670
| -6% | -$1.43M | 1.78% | 13 |
|
|
2023
Q2 | $24.3M | Buy |
146,695
+87,760
| +149% | +$14.2M | 1.86% | 11 |
|
|
2023
Q1 | $9.13M | Buy |
58,935
+711
| +1% | +$115K | 0.72% | 29 |
|
|
2022
Q4 | $10.3M | Sell |
58,224
-3,127
| -5% | -$540K | 0.81% | 28 |
|
|
2022
Q3 | $10M | Buy |
61,351
+682
| +1% | +$115K | 0.84% | 27 |
|
|
2022
Q2 | $10.8M | Buy |
60,669
+5,313
| +10% | +$947K | 0.8% | 28 |
|
|
2022
Q1 | $9.81M | Sell |
55,356
-265
| -0.5% | -$45.1K | 0.63% | 38 |
|
|
2021
Q4 | $9.52M | Buy |
55,621
+827
| +2% | +$135K | 0.59% | 44 |
|
|
2021
Q3 | $8.85M | Buy |
54,794
+328
| +0.6% | +$56K | 0.56% | 43 |
|
|
2021
Q2 | $8.97M | Sell |
54,466
-7,245
| -12% | -$1.2M | 0.58% | 44 |
|
|
2021
Q1 | $10.1M | Sell |
61,711
-1,421
| -2% | -$230K | 0.76% | 35 |
|
|
2020
Q4 | $9.94M | Sell |
63,132
-1,740
| -3% | -$257K | 0.74% | 38 |
|
|
2020
Q3 | $9.66M | Sell |
64,872
-1,476
| -2% | -$218K | 0.82% | 35 |
|
|
2020
Q2 | $9.33M | Buy |
66,348
+1,881
| +3% | +$274K | 0.86% | 31 |
|
|
2020
Q1 | $8.45M | Sell |
64,467
-671
| -1% | -$95.2K | 0.93% | 29 |
|
|
2019
Q4 | $9.5M | Sell |
65,138
-4,430
| -6% | -$601K | 0.93% | 30 |
|
|
2019
Q3 | $9M | Sell |
69,568
-178
| -0.3% | -$23.5K | 0.95% | 28 |
|
|
2019
Q2 | $9.71M | Sell |
69,746
-3,945
| -5% | -$546K | 1.03% | 25 |
|
|
2019
Q1 | $10.3M | Sell |
73,691
-1,341
| -2% | -$180K | 1.19% | 19 |
|
|
2018
Q4 | $9.68M | Buy |
75,032
+518
| +0.7% | +$72.3K | 1.28% | 15 |
|
|
2018
Q3 | $10.3M | Buy |
74,514
+4,714
| +7% | +$626K | 1.2% | 17 |
|
|
2018
Q2 | $8.47M | Buy |
+69,800
| New | +$8.71M | 1.07% | 22 |
|
Other funds holding JNJ
VCM
VPM
Equitable Trust's JNJ Position: Q1 2026 in Review
Equitable Trust increased its Johnson & Johnson (JNJ) stake by 0.27% in Q1 2026, buying an estimated $33.1K and bringing the position to 52,651 shares worth $12.9M. The position accounts for 0.59% of the portfolio, ranked #38.
Equitable Trust first reported a position in JNJ in Q2 2018 and has held it in 32 quarters since. The position peaked at $24.3M in Q2 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Equitable Trust held 52,651 shares of Johnson & Johnson worth $12.9M as of Q1 2026.
- Equitable Trust bought 142 Johnson & Johnson shares in Q1 2026, an estimated $33.1K.
- Johnson & Johnson made up 0.59% of Equitable Trust's portfolio in Q1 2026, its #38 holding.
- Equitable Trust first reported a position in Johnson & Johnson in Q2 2018 and has held it in 32 quarters since.
- Equitable Trust's Johnson & Johnson position peaked at $24.3M in Q2 2023.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.